RLMD
Relmada Therapeutics Inc.
Company Overview
| Mkt Cap | $50.78M | Price | $2.26 |
| Volume | 54.78K | Change | -2.59% |
| P/E Ratio | -0.6 | Open | $2.31 |
| Revenue | -- | Prev Close | $2.32 |
| Net Income | $-80.0M | 52W Range | $0.24 - $3.67 |
| Div Yield | N/A | Target | $1.00 |
| Overall | 49 | Value | 60 |
| Quality | 23 | Technical | 66 |
No chart data available
Stock Overview
Updated DailyRelmada Therapeutics Inc. (RLMD) is a leading Healthcare company in the Drug Manufacturers - Specialty & Generic industry, currently trading at $2.26 with a market capitalization of $50.78 million. The stock is trading in the middle of its 52-week range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 23.
Today's trading session shows RLMD with a volume of 55K shares. The stock opened down 0.43% from yesterday's close of $2.32. Current analyst estimates project earnings of $NA per share for this year, with next year targeting $-0.05.
RLMD demonstrates positive technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including CLCS, ETST, TARO, CYTK.
Key investment considerations for RLMD include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest limited upside of -55.8%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 10:57 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RLMD | $2.26 | -2.6% | 54.78K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Relmada Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW